TP53 and cancer: In almost all human cancers, p53 function is inactivated mainly by mutations and/or down-regulation; the latter being driven essentially by ubiquitin ligases such as Mouse double minute 2 (MDM2) and Constitutive Photomorphogenic Protein 1 (COP1) [8].